Partnering

Partnering and innovating with Alexza

Alexza is always looking for partners in innovation. We are looking for developmental and commercial partners for our pipeline programs, and we welcome partnering your molecules that could benefit from Staccato® One Breath Technology™ – OBT™.

We are interested in developing products across different therapeutic areas where speed of onset and non-invasive delivery make a difference. See our pipeline for ongoing research and therapeutic areas. We have explored multiple therapeutic areas and actives, including:

  • Breakthrough pain
  • Middle-of-the-night awakening
  • Movement disorders
  • Migraine
  • Nausea and vomiting
  • Nicotine
  • Cannabinoids
  • Acute allergic reactions

Leveraging development work that has already been completed, we are interested in partnering and/or collaboration to meet Partners’ needs:

  • Delivering NCEs that could benefit from non-invasive, IV-like systemic delivery
  • Need for non-oral delivery
  • Compounds with poor solubility, low oral bioavailability, or high first-pass metabolism
  • Products currently available as IV formulations (i.e., maintain PK profile, remove the need for the needles)
  • Improved side effect profile
  • Life-cycle management of the products
  • Intellectual property coverage expansion

We have screened many compounds and actives for feasibility in our technology across a large number of therapeutic areas. From more than 400 compounds screened, over 50% of them have been technically feasible with Staccato technology.

Partner with Alexza through licensing relationship, research collaboration or strategic alliance.

To date we have screened more than 400 compounds

More than 200+ are compatible with our Staccato platform

For more information about our programs click here.

For more information about pipeline opportunities click here.

To discuss partnership and licensing opportunities, please contact our Business Development Group

Staccato OBT Staccato Logo